The present invention relates to compounds of formula (I)
which inhibit acetyl-CoA carboxylase (ACC) and are useful for the prevention or treatment of metabolic syndrome, type II diabetes, obesity, atherosclerosis and cardiovascular diseases in humans.
本发明涉及式(I)化合物,该化合物抑制
乙酰辅酶A羧化酶(ACC),并可用于预防或治疗人类代谢综合征、2型糖尿病、肥胖症、动脉硬化和心血管疾病。